Total Payments
$196,802
2024 Payments
$10,818
Companies
48
Transactions
877
Medicare Patients
5,451
Medicare Billing
$682,483
Payment Breakdown by Category
Other$154,846 (78.7%)
Consulting$18,550 (9.4%)
Food & Beverage$13,230 (6.7%)
Travel$9,685 (4.9%)
Education$491.45 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $154,822 | 68 | 78.7% |
| Consulting Fee | $18,550 | 15 | 9.4% |
| Food and Beverage | $13,230 | 743 | 6.7% |
| Travel and Lodging | $9,685 | 40 | 4.9% |
| Education | $491.45 | 10 | 0.2% |
| Entertainment | $23.80 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $130,350 | 228 | $0 (2024) |
| Mylan Specialty L.P. | $34,679 | 135 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $23,230 | 93 | $0 (2024) |
| Chiesi USA, Inc. | $1,906 | 3 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $761.96 | 56 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $489.71 | 19 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $472.22 | 24 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $468.17 | 21 | $0 (2024) |
| Electromed, Inc. | $441.89 | 48 | $0 (2024) |
| ABBVIE INC. | $404.54 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,818 | 101 | Mylan Specialty L.P. ($6,006) |
| 2023 | $51,984 | 160 | GlaxoSmithKline, LLC. ($43,550) |
| 2022 | $27,657 | 121 | GlaxoSmithKline, LLC. ($18,764) |
| 2021 | $16,367 | 92 | GlaxoSmithKline, LLC. ($13,492) |
| 2020 | $24,734 | 64 | GlaxoSmithKline, LLC. ($18,173) |
| 2019 | $46,812 | 157 | GlaxoSmithKline, LLC. ($32,321) |
| 2018 | $7,317 | 91 | AstraZeneca Pharmaceuticals LP ($6,448) |
| 2017 | $11,114 | 91 | AstraZeneca Pharmaceuticals LP ($10,159) |
All Payment Transactions
877 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/17/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $9.81 | General |
| Category: HFCWO | ||||||
| 12/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Respiratory | ||||||
| 12/06/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $6.75 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/04/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $7.53 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/06/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $19.43 | General |
| 11/06/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Cardio-pulmonary | ||||||
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Respiratory | ||||||
| 10/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Immunology | ||||||
| 10/18/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $6.95 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/11/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $11.41 | General |
| Category: HFCWO | ||||||
| 10/10/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/08/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/08/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Pulmonology | ||||||
| 10/02/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: ANTIBIOTIC | ||||||
| 09/23/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $9.53 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/17/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $3.51 | General |
| Category: HFCWO | ||||||
| 09/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: RESPIRATORY | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,217 | 7,707 | $360,935 | $142,782 |
| 2022 | 12 | 1,417 | 8,590 | $400,110 | $164,044 |
| 2021 | 12 | 1,305 | 9,776 | $436,837 | $186,210 |
| 2020 | 12 | 1,512 | 12,185 | $509,065 | $189,447 |
Total Patients
5,451
Total Services
38,258
Medicare Billing
$682,483
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 479 | 872 | $156,960 | $79,053 | 50.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 154 | 154 | $46,200 | $18,110 | 39.2% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 58 | 1,328 | $26,560 | $14,092 | 53.1% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 42 | 2,946 | $29,460 | $8,245 | 28.0% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 56 | 1,027 | $30,810 | $8,009 | 26.0% |
| 31645 | Aspiration of initial secretion of lung airway using an endoscope | Facility | 2023 | 12 | 52 | $30,940 | $5,564 | 18.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 82 | 82 | $9,840 | $3,344 | 34.0% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 82 | 82 | $9,020 | $2,571 | 28.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 87 | 87 | $15,225 | $2,375 | 15.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 123 | 1,015 | $4,060 | $840.34 | 20.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 42 | 62 | $1,860 | $577.74 | 31.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 525 | 968 | $174,240 | $90,572 | 52.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 178 | 178 | $53,400 | $21,556 | 40.4% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 66 | 1,377 | $27,540 | $15,524 | 56.4% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 45 | 3,240 | $32,400 | $9,275 | 28.6% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 63 | 998 | $29,940 | $7,817 | 26.1% |
| 31645 | Aspiration of initial secretion of lung airway using an endoscope | Facility | 2022 | 16 | 53 | $31,535 | $5,837 | 18.5% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 98 | 99 | $11,880 | $4,265 | 35.9% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 98 | 99 | $10,890 | $3,203 | 29.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 104 | 105 | $18,375 | $3,024 | 16.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 157 | 1,375 | $5,500 | $1,194 | 21.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 14 | $1,890 | $953.68 | 50.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 53 | 84 | $2,520 | $822.68 | 32.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 506 | 1,040 | $187,200 | $102,062 | 54.5% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 82 | 1,920 | $38,400 | $22,569 | 58.8% |
About Dr. John Southard, MD
Dr. John Southard, MD is a Pulmonary Disease healthcare provider based in Council Bluffs, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1104967090.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Southard, MD has received a total of $196,802 in payments from pharmaceutical and medical device companies, with $10,818 received in 2024. These payments were reported across 877 transactions from 48 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($154,822).
As a Medicare-enrolled provider, Southard has provided services to 5,451 Medicare beneficiaries, totaling 38,258 services with total Medicare billing of $682,483. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Council Bluffs, IA
- Active Since 02/12/2007
- Last Updated 07/08/2007
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1104967090
Products in Payments
- TRELEGY ELLIPTA (Drug) $74,755
- AREXVY (Drug) $26,243
- Yupelri (Drug) $26,172
- BEVESPI AEROSPHERE (Drug) $10,078
- YUPELRI (Drug) $8,429
- FASENRA (Drug) $7,511
- ANORO (Drug) $3,765
- DUPIXENT (Biological) $700.54
- FASENRA (Biological) $611.45
- NUCALA (Biological) $517.90
- SMARTVEST (Device) $441.89
- OFEV (Drug) $416.16
- Wakix (Drug) $340.04
- ACTHAR (Biological) $330.20
- BREZTRI (Drug) $329.52
- OPSUMIT (Drug) $279.57
- Prolastin-C Liquid (Biological) $225.89
- AVYCAZ (Drug) $219.75
- Xolair (Biological) $205.50
- DALVANCE (Drug) $203.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.